PERSONALIZED ACTIVE IMMUNOTHERAPY

Clinical trials for PERSONALIZED ACTIVE IMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new PERSONALIZED ACTIVE IMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for PERSONALIZED ACTIVE IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New vaccine aims to keep leukemia in remission

Disease control Recruiting now

This study tests a personalized vaccine made from a patient's own leukemia cells to help prevent the cancer from coming back. It is for adults with acute myeloid leukemia who are in remission after initial chemotherapy. The vaccine is designed to train the immune system to recogn…

Matched conditions: PERSONALIZED ACTIVE IMMUNOTHERAPY

Phase: PHASE1 • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control

Last updated May 17, 2026 02:44 UTC

PERSONALIZED ACTIVE IMMUNOTHERAPY

Get alerted when new PERSONALIZED ACTIVE IMMUNOTHERAPY trials appear

New vaccine aims to keep leukemia in remission